Joon Y. Lee

Dr. Joon Y. Lee


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 April 2023 in Biomolecules
Verified
Journal Article
Open access
PDF file
PSPrashanta Silwal
Prashanta Silwal
ANAllison Nguyen-Thai
Allison Nguyen-Thai
HMHaneef Ahamed Mohammad
Haneef Ahamed Mohammad
YWYanshan Wang
Yanshan Wang
PRPaul Robbins
Paul Robbins
NVNam V. Vo
Nam V. Vo
Closely associated with aging and age-related disorders, cellular senescence (CS) is the inability of cells to proliferate due to accumulated unrepaired cellular damage and irreversible cell cycle arrest. Senescent cells are characterized by their senescence-associated secretory phenotype that overproduces inflammatory and catabolic factors that hamper normal tissue homeostasis. Chronic accumulation of senescent cells is thought to be associated with intervertebral disc degeneration (IDD) in an aging population. This IDD is one of the largest age-dependent chronic disorders, often associated with neurological dysfunctions such as, low back pain, radiculopathy, and myelopathy. Senescent cells (SnCs) increase in number in the aged, degenerated discs, and have a causative role in driving age-related IDD. This review summarizes current evidence supporting the role of CS on onset and progression of age-related IDD. The discussion includes molecular pathways involved in CS such as p53-p21CIP1, p16INK4a, NF-κB, and MAPK, and the potential therapeutic value of targeting these pathways. We propose several mechanisms of CS in IDD including mechanical stress, oxidative stress, genotoxic stress, nutritional deprivation, and inflammatory stress. There are still large knowledge gaps in disc CS research, an understanding of which will provide opportunities to develop therapeutic interventions to treat age-related IDD.

10 October 2024 in Biomolecules
Verified
Journal Article
Open access
PDF file
PSPrashanta Silwal
Prashanta Silwal
ANAllison Nguyen-Thai
Allison Nguyen-Thai
PAPeter G Alexander
Peter G Alexander
GSGwendolyn A Sowa
Gwendolyn A Sowa
NVNam V. Vo
Nam V. Vo
JLJoon Y. Lee
Joon Y. Lee
Hypertrophy of the ligamentum flavum (HLF) is a common contributor to lumbar spinal stenosis (LSS). Fibrosis is a core pathological factor of HLF resulting in degenerative LSS and associated low back pain. Although progress has been made in HLF research, the specific molecular mechanisms that promote HLF remain to be defined. The molecular factors involved in the onset of HLF include increases in inflammatory cytokines such as transforming growth factor (TGF)-β, matrix metalloproteinases, and pro-fibrotic growth factors. In this review, we discuss the current understanding of the mechanisms involved in HLF with a particular emphasis on aging and mechanical stress. We also discuss in detail how several pathomechanisms such as fibrosis, proliferation and apoptosis, macrophage infiltration, and autophagy, in addition to several molecular pathways involving TGF-β1, mitogen-activated protein kinase (MAPKs), and nuclear factor-κB (NF-κB) signaling, PI3K/AKT signaling, Wnt signaling, micro-RNAs, extracellular matrix proteins, reactive oxygen species (ROS), etc. are involved in fibrosis leading to HLF. We also present a summary of the current advancements in preclinical animal models for HLF research. In addition, we update the current and potential therapeutic targets/agents against HLF. An improved understanding of the molecular processes behind HLF and a novel animal model are key to developing effective LSS prevention and treatment strategies.

1 October 2012 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
PDF file
ACAntonia F. Chen
Antonia F. Chen
SCSrinivas Chivukula
Srinivas Chivukula
LJLloydine J. Jacobs
Lloydine J. Jacobs
MTMatthew W. Tetreault
Matthew W. Tetreault
JLJoon Y. Lee
Joon Y. Lee
The incidence of methicillin-resistant Staphylococcus aureus (MRSA) infection is increasing. However, the prevalence of MRSA colonization among patients undergoing spine surgery is unclear. We therefore (1) determined the prevalence of MRSA colonization in a population of patients scheduled for elective spine surgery; and (2) evaluated whether MRSA screening and treatment reduce the rate of early wound complications. We retrospectively reviewed prospectively collected data from 1002 patients undergoing elective spine surgery in 2010. There were 719 primary and 283 revision surgeries. Instrumentation was used in 72.0% cases and autologous iliac crest bone graft was taken in 65.1%. Twelve patients were lost to followup; of the remaining 990 patients, 503 were screened for MRSA and 487 were not. MRSA-colonized patients were treated with mupirocin and chlorhexidine. An early wound complication was defined as wound drainage or the presence of an abscess. Patients were followed for a minimum of 3 months (average, 7 months; range, 3–545 days). Of the patients undergoing elective spine surgery and screened for MRSA, 14 of 503 (2.8%) were colonized with MRSA. The rates of early wound complications were similar for patients who were screened and pretreated for MRSA (17 of 503 [3.4%]) compared with those who were not (17 of 487 [3.5%]). The colonization rate for MRSA in our elective spine surgery population was comparable to that in the arthroplasty literature. Level III, retrospective comparative study. See the Guidelines for Authors for a complete description of levels of evidence.

1 February 2019 in The Spine Journal
Verified
Journal Article
Closed access
MDMalcolm E. Dombrowski
Malcolm E. Dombrowski
AMAlejandro Morales-Restrepo
Alejandro Morales-Restrepo
Mitchell S. FourmanMitchell S. Fourman
Mitchell S. Fourman
NVNicholas Vaudreuil
Nicholas Vaudreuil
JLJoon Y. Lee
Joon Y. Lee

Verified
Journal Article
Open access
PDF file
JZJiongbiao Zhong
Jiongbiao Zhong
JCJoseph Chen
Joseph Chen
AOAnthony Abimbade Oyekan
Anthony Abimbade Oyekan
MEMichael Wayne Epperly
Michael Wayne Epperly
JGJoel Greenberger
Joel Greenberger
NVNam V. Vo
Nam V. Vo
Previous research has identified an association between external radiation and disc degeneration, but the mechanism was poorly understood. This study explores the effects of ionizing radiation (IR) on inducing cellular senescence of annulus fibrosus (AF) in cell culture and in an in vivo mouse model. Exposure of AF cell culture to 10–15 Gy IR for 5 min followed by 5 days of culture incubation resulted in almost complete senescence induction as evidenced by SA-βgal positive staining of cells and elevated mRNA expression of the p16 and p21 senescent markers. IR-induced senescent AF cells exhibited increased matrix catabolism, including elevated matrix metalloproteinase (MMP)-1 and -3 protein expression and aggrecanolysis. Analogous results were seen with whole body IR-exposed mice, demonstrating that genotoxic stress also drives disc cellular senescence and matrix catabolism in vivo. These results have important clinical implications in the potential adverse effects of ionizing radiation on spinal health.

7 August 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
PMPeter N. Mittwede
Peter N. Mittwede
AMAlejandro Morales-Restrepo
Alejandro Morales-Restrepo
Mitchell S. FourmanMitchell S. Fourman
Mitchell S. Fourman
FFFreddie H. Fu
Freddie H. Fu
JLJoon Y. Lee
Joon Y. Lee
MHMaCalus Hogan
MaCalus Hogan
Background: The importance of research in resident education has been emphasized in the orthopaedic surgery community, and a number of residency programs have incorporated a year or more of protected research time into their training. However, limited information exists as to what programs are looking for in applicants to research-track residency programs or the perceived benefits of completing such a program. Methods: We identified orthopaedic surgery programs that have tracks involving at least 1 year of protected research time and sent surveys to their program directors and to the 2012 through 2016 research-track graduates. Results: Twenty-three programs with research tracks were identified, and 19 program directors (83%) responded to the survey. The survey revealed that only 2 (11%) of these program directors were willing to accept lower scores and grades among applicants to their research track compared with their primary clinical (categorical) track. While most of the program directors (14 [74%]) preferred that applicants have an interest in academics, only a few (3 [16%]) considered it a failure if their research-track residents did not pursue academic careers. We obtained the e-mail addresses of 82 research-track graduates, and 66 (80%) responded to the survey. The survey revealed that those who went into academic careers were more likely than those who went into private practice to view completing a research track as beneficial for fellowship (73% versus 35%, respectively) and job (73% versus 22%, respectively) applications, believed that the income lost from the additional year of residency would be compensated for by opportunities gained from the research year (50% versus 17%, respectively), and said that they would pursue a research-track residency if they had to do it over again (81% versus 39%, respectively; all p values <0.05). Conclusions: The majority of program directors preferred that applicants to their research-track program have an interest in academics, although most did not consider it a failure if their research-track residents entered nonacademic careers. Graduates of research-track residency programs who entered academics more frequently viewed the completion of a research track as being beneficial compared with those who went into private practice.